Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That is incorrect on sbfm. The first manufacturer failed to be able to make the drug in quantities sufficient for phase 1. Lonza just accomplished recently. Drug will be delivered Q1. So sbfm different than biei. Adva-27 is a TOP2 with a known mechanism and predictable safety profile because it is a known medication. It was tested preclinically identically to etoposide with superior efficacy.
I have 50000 Tpiv. Already.
Aren't they pennies because we are super early? And nothing is proven until FDA approval. Just look at Srpt. Bio is a total loss potentially in many if not most stocks. Just about the science and management. At least we have the science in both and management in one
Thoughts on this crude?
You are probably right for today. We shall see in a couple of weeks. I got in because it was down 99% and has some really good products likely to approve. And that would mean a Mc far higher than here. They day to day debauchery in biotech is what it is. Ivan
Me yiu re saying that all those 25 million shares yesterday including huge block buys had no idea that R/S announcement was coming? They always know
Bouncing off support always means something. And high volume Pm is not meaningless
We shall see. You may be right. But the R/S could be a standard practice and ploy to get rid of the shares before approval as well. Or do you think these things operate on the up and up?
Why did it bounce so hard at .20 then?
You are either selling today and rebuying or holding for
The approval. These day to day decisions rarely mean much in this kind of stock. I have a small position taken at .20. Not worried. By April. I will be significantly green!!
The warrants out us at .20 and a lot of people that are more powerful than us want it above .20
Yes we are!
Resistance or support!!??
I always think that is a possibility. Also. Huge block buys 100 million shares. Like the Mm's didn't know this already!!
I really don't understand the point of this none. It will open down 50% so I am
Just holding. I didn't get in until .20 last week anyway
I
Can't stand small bios! No care for shareholders!! Lol
Why would
It
Break? This
R/S gives the short cabal
All
They need to
Run this down
You keep saying that!! Hopefully you will be right eventually. Lol. Ivan
Oh please!!
Are we both in this one too? Lol. Ivan
Thinking you may be right. Bought in at .20 last week
I have been watching this since .14 before the 1/60. You feel as though nothing is different today with the C warrants being fully converted and only minimal dilution possible starting in April? Not trying to be cute. Just asking. Thanks again. Ivan
What does it change other than sentiment? And I isn't bash you. Lol. Ivan
Said what. I honestly don't understand what the horror is. Dilution over in any substantive amounts. FDA approval coming and they want to stay on Nasdaq.
Can't wait for februAry for almost every bio I own. Ivan
R/s does nothing to mRket cap. Who cares!!
That's what I am thinking with all my frigging bios
Well my biei and sbfm are safer than every other bio I own except Gbsn!! Lol
What is the meaning of that?
Dr Ivan is down from his .018 investment avg. just means I am down the most!!
Like that!!
Love Arizona. Loved there as kid. My wife won't move
No. But the valuation has a long way to go. We need the jv first.
And the fact that it is in 2020. Jeez
I agree. Just makes the rest of your shares worth more anyway. Lol
You don't need to repeat phase1 or 2A with the same drug. Did you read their PR? Avxl states they were heading two pivotal trials in 2016 one for alz the other for an undisclosed indication. What else would it be other than epilepsy? They don't have any other indications or drugs far enough along.
What is the difference between a pivotal 2B and phase 3 in an adaptive trial with 300 patients powered appriproately
We won't need much for the first move to .10. Imho
Yes!!